Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRTC NASDAQ:ISRG NYSE:PATH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$113.90-1.5%$118.83$108.81▼$212.00$3.80B1.33560,614 shs320,373 shsISRGIntuitive Surgical$424.59+0.2%$453.54$414.30▼$603.88$150.39B1.512.14 million shs3.44 million shsPATHUiPath$11.69+0.9%$10.73$9.20▼$19.84$6.07B0.9136.68 million shs64.85 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies-1.48%-2.28%-5.67%-14.84%-19.43%ISRGIntuitive Surgical+0.23%-3.08%-6.44%-15.67%-23.14%PATHUiPath+0.77%+7.10%+12.25%+8.69%-10.08%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$113.90-1.5%$118.83$108.81▼$212.00$3.80B1.33560,614 shs320,373 shsISRGIntuitive Surgical$424.59+0.2%$453.54$414.30▼$603.88$150.39B1.512.14 million shs3.44 million shsPATHUiPath$11.69+0.9%$10.73$9.20▼$19.84$6.07B0.9136.68 million shs64.85 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies-1.48%-2.28%-5.67%-14.84%-19.43%ISRGIntuitive Surgical+0.23%-3.08%-6.44%-15.67%-23.14%PATHUiPath+0.77%+7.10%+12.25%+8.69%-10.08%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRTCiRhythm Technologies 2.93Moderate Buy$191.8568.43% UpsideISRGIntuitive Surgical 2.67Moderate Buy$576.7135.83% UpsidePATHUiPath 2.06Hold$14.0019.76% UpsideCurrent Analyst Ratings BreakdownLatest ISRG, IRTC, and PATH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2026PATHUiPath DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$13.00 ➝ $12.005/29/2026PATHUiPath Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderperform$12.00 ➝ $13.005/29/2026PATHUiPath Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$17.00 ➝ $15.005/29/2026PATHUiPath Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.005/27/2026ISRGIntuitive Surgical The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$558.005/19/2026ISRGIntuitive Surgical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)5/18/2026IRTCiRhythm Technologies Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$225.00 ➝ $180.005/18/2026ISRGIntuitive Surgical Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$650.00 ➝ $520.005/4/2026IRTCiRhythm Technologies CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$155.00 ➝ $157.005/1/2026IRTCiRhythm Technologies Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$198.00 ➝ $180.005/1/2026IRTCiRhythm Technologies JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$215.00 ➝ $175.00(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRTCiRhythm Technologies$787.85M4.75N/AN/A$4.91 per share23.20ISRGIntuitive Surgical$10.58B14.21$9.30 per share45.66$49.69 per share8.54PATHUiPath$1.61B3.80$0.39 per share29.66$3.88 per share3.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRTCiRhythm Technologies-$44.55M-$0.86N/A86.95N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)ISRGIntuitive Surgical$2.86B$8.2551.4743.283.3828.15%15.98%14.07%7/28/2026 (Estimated)PATHUiPath$282.33M$0.5219.4829.231.9019.58%7.94%5.20%N/ALatest ISRG, IRTC, and PATH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2026Q1 2027PATHUiPath$0.15$0.15N/A$0.04$397.54 million$418.38 million4/30/2026Q1 2026IRTCiRhythm Technologies-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million4/21/2026Q1 2026ISRGIntuitive Surgical$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion3/11/2026Q4 2026PATHUiPath$0.25$0.30+$0.05$0.19$464.81 million$481.11 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIRTCiRhythm TechnologiesN/AN/AN/AN/AN/AISRGIntuitive SurgicalN/AN/AN/AN/AN/APATHUiPathN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRTCiRhythm Technologies4.035.174.98ISRGIntuitive SurgicalN/A4.613.59PATHUiPathN/A2.482.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRTCiRhythm TechnologiesN/AISRGIntuitive Surgical83.64%PATHUiPath62.50%Insider OwnershipCompanyInsider OwnershipIRTCiRhythm Technologies0.98%ISRGIntuitive Surgical0.60%PATHUiPath22.44%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRTCiRhythm Technologies2,40032.86 million32.54 millionOptionableISRGIntuitive Surgical17,021354.16 million352.04 millionOptionablePATHUiPath3,981523.92 million406.35 millionOptionableISRG, IRTC, and PATH HeadlinesRecent News About These CompaniesUiPath (NYSE:PATH) Given "Buy" Rating at Needham & Company LLCMay 30 at 4:56 AM | americanbankingnews.comUiPath (NYSE:PATH) Price Target Cut to $15.00 by Analysts at Morgan StanleyMay 30 at 3:27 AM | americanbankingnews.comUiPath (NYSE:PATH) Downgraded to Hold Rating by Wall Street ZenMay 30 at 1:39 AM | marketbeat.comUiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/YMay 29 at 6:08 PM | finance.yahoo.comUiPath Stock Falls After Weak Earnings Despite ARR Tops $1.9 BillionMay 29 at 6:08 PM | finance.yahoo.comUiPath Q1 Earnings In Line With Estimates, Revenues Increase Y/YMay 29 at 1:26 PM | zacks.comUipath expects FY2027 revenue $1.776B-$1.781B while raising non-GAAP operating income outlook to ~$430MMay 29 at 1:07 PM | seekingalpha.comUiPath (PATH) Valuation Check After Recent Share Price Momentum And Long Term WeaknessMay 29 at 1:07 PM | finance.yahoo.comMorgan Stanley Has Lowered Expectations for UiPath (NYSE:PATH) Stock PriceMay 29 at 11:55 AM | marketbeat.comUiPath (NYSE:PATH) Shares Gap Down - Time to Sell?May 29 at 11:35 AM | marketbeat.comUiPath Inc (PATH) Q1 2027 Earnings Call Highlights: Record Revenue and First-Time GAAP ProfitabilityMay 29 at 8:06 AM | finance.yahoo.comPATH Q1 Deep Dive: AI Product Expansion and Operational Efficiency Define QuarterMay 29 at 8:06 AM | finance.yahoo.comUiPath's (PATH) "Buy" Rating Reaffirmed at Needham & Company LLCMay 29 at 8:06 AM | marketbeat.comUiPath, Inc. (PATH) Q1 2027 Earnings Call TranscriptMay 29 at 7:00 AM | seekingalpha.comTraders Buy Large Volume of UiPath Call Options (NYSE:PATH)May 29 at 4:11 AM | americanbankingnews.comUiPath Swings to 1Q Profit As Demand For AI Agents GrowsMay 28 at 10:57 PM | marketwatch.comUiPath: Fiscal Q1 Earnings SnapshotMay 28 at 10:57 PM | chron.comUiPath (PATH) Q1 Earnings Meet EstimatesMay 28 at 10:57 PM | finance.yahoo.comUiPath (PATH) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesMay 28 at 10:57 PM | finance.yahoo.comPATH Stock Slips After-Hours On Q1 Earnings Miss, But Q2 And Full-Year Guidance Beats ExpectationsMay 28 at 10:57 PM | stocktwits.comSUiPath (PATH) Q1 2027 Earnings TranscriptMay 28 at 10:57 PM | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeISRG, IRTC, and PATH Company DescriptionsiRhythm Technologies NASDAQ:IRTC$113.90 -1.71 (-1.48%) Closing price 05/29/2026 04:00 PM EasternExtended Trading$114.01 +0.11 (+0.10%) As of 05/29/2026 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Intuitive Surgical NASDAQ:ISRG$424.59 +0.96 (+0.23%) Closing price 05/29/2026 03:59 PM EasternExtended Trading$424.70 +0.11 (+0.03%) As of 05/29/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.UiPath NYSE:PATH$11.69 +0.11 (+0.95%) Closing price 05/29/2026 03:59 PM EasternExtended Trading$11.74 +0.05 (+0.43%) As of 05/29/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/25 - 05/29 Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17% Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem MongoDB's AI Advantage Is Starting to Show Up in Results Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys Dollar Tree Keeps Winning After Family Dollar Divorce Salesforce Stock Finds Support as AI Momentum Builds These 3 Software Stocks Are Buying Back Shares Hand Over Fist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
